Aviva plc commits further £150 million to Aviva Ventures and invests the first £1.5 million in Scan.com

Aviva today announces the commitment of a further £150m to its corporate venture capital fund, Aviva Ventures. The fund will focus on delivering returns through investments into early stage businesses that bring Aviva new opportunities and insights into emerging technology and customer trends.

Aviva is also announcing the new fund's first investment, an investment in Scan.com, a business helping individuals and organisations book diagnostics scans such as MRI, ultrasounds and x-rays. Scan.com launched in 2017 and has a network of 150 scanning centres across the UK. Scan.com has helped over 10,000 patients and is now the UK market leader in medical imaging services.

Ben Luckett, Chief Innovation Officer at Aviva, said:

"Innovation is central to Aviva's strategy and our ambition to deliver great outcomes for our customers. The £150m commitment to Aviva Ventures will be used to make early stage investments in promising young digital and tech firms that also provide us with insight on emerging technology and consumer trends.

"Our investment in Scan.com is a statement of our intent - they are growing rapidly, have a unique customer proposition and are already leading the way on medical imaging services in the UK. We are really excited to support Scan.com's development and growth."

Charlie Bullock, co-founder and CEO of Scan.com, said:

"We are thrilled to have such strong support from Aviva as we continue to build Scan.com across the UK. The capital will be used to continue to improve access to diagnostic imaging and medical screening exams, through our consumer facing marketplace and application programming interfaces (API). This round would not have been possible without the incredible effort and tenacity shown by our entire team, who have built Scan.com at such a fast pace in what is traditionally a very slow-moving industry."

-ENDS-

Further information

About Aviva Ventures

• Aviva Ventures was set up in 2016 with an initial £100m investment, as part of Aviva's commitment to innovation. The fund focuses on investments where Aviva can develop a strategic relationship. Investment themes include customer wellbeing, mobility, sustainability, and the opportunities created by new technology developments like Artificial Intelligence. Previous investments include Tembo Money, Outdoorsy, Shepper and Owlstone Medical.

About Scan.com

• Scan.com launched in 2017 and has a network of 150 scanning centres across the UK. Scan.com has helped over 10,000 patients and is now the UK market leader in medical imaging services, receiving referrals from hundreds of clinicians, consultants, health insurers and telehealth providers every month. Scan.com can deliver results to patients in as little as a week, reducing waiting times and improving patient care outcomes. Aviva has supported Scan.com since 2021, when they joined Aviva's innovation partner Founders Factory as part of their accelerator programme.
• Scan.com began as a side project, co-founded by clinicians who experienced inefficiencies when trying to organise diagnostics for their patients.
• Scan.com's mission is to make medical imaging accessible for everyone. It offers an appointment booking engine for patients, a portal for referring providers, and an API for digital health partners, across the UK and the USA.
• Their 2021 $2m seed round, co-led by Oxford Capital and YZR, and backed by notable angel investors including Tom Blomfield (ex-Monzo) and Evelyn Bourke (ex-BUPA), launched Scan.com full-time. Supercharged by a subsequent $2.2m extension in 2022 led by Triple Point Ventures, the team is now 30-strong across the UK and US.

Enquiries:

Media:

Sarah Swailes

+44 (0)7800 694 859

Joe Booth

+44 (0)7800 698 836

Analysts:

Rupert Taylor Rea

+44 (0)7385 494 440

Joel von Sternberg

+44 (0)7384 231 238

Michael O'Hara

+44 (0)7837 234 388

Attachments

• Original Link
• Original Document
• Permalink

Disclaimer

Aviva plc published this content on 17 April 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 April 2023 10:51:55 UTC.